NUVO
Nuvelo Inc
Biopharmaceutical company focused on the discovery, development and commercialization of drugs for acute cardiovascular disease, cancer, and other debilitating medical conditions
CUSIP: 67072M301HealthcareUS1 holder
Nuvelo Inc
Biopharmaceutical company focused on the discovery, development and commercialization of drugs for acute cardiovascular disease, cancer, and other debilitating medical conditions
No insider transactions reported in the last 6 months. Look across all recorded history →